We observed that a methanolic whole body extract of uninfected last instar larvae of the housefly, Musca domestica, displayed antifungal and antibacterial activity. We have further purified this extract to a single active fraction using reversed phase high performance liquid chromatography. The pure fraction inhibited growth of the Gram-positive bacteria Bacillus thuringiensis and the yeast Saccharomyces cerevisiae, but not the Gram-negative bacteria Escherichia coli. The active compound was determined to have a molecular mass of 451.2 Da. Further analysis by nuclear magnetic resonance identified the substance as mono-unsaturated 1-lysophosphatidylethanolamine (C 16:1 ) (1-LPE). The structurally different and more common 2-LPE have been described as mediators of the antimicrobial activity of rimenophenazine antibiotic agents (Van Rensburg et al., 1992) . Our results suggest that the isolated 1-LPE displays a higher activity in comparison, possibly based on structure-specific differences in activity. 
Introduction
The intensive application of antibiotic agents in health care and animal breeding during the last decades has created a continuous selective pressure on microorganisms. This has promoted the growth and spread of microorganisms that display resistance against one or several of the present antimicrobial agents. The development of novel antimicrobial agents requires novel active lead-compounds. The innate immune system of insects has proven to be a source of a large variety of such compounds and in particular of antimicrobial peptides (Bulet et al., 1999; Otvos, 2000) . However, the identification of non-peptidergic, low molecular mass compounds with antimicrobial activity has, in comparison, been very limited (Leem et al., 1996 (Leem et al., , 1999 Meylaers et al., 2003) .
In general, the expression of antimicrobial effectors is induced only upon wounding and/or infection. As such, the reported purifications were mainly initiated from immunised insects, meaning that the innate immune response was induced by an experimental infection with pathogens or prepared fractions of these pathogens. Reports on constitutively expressed antimicrobial compounds in insects are yet few (Daffre et al., 1994; Yang et al., 1998; Lamberty et al., 2001) . It is known, however, that a constitutive expression and storage of antibacterial peptides occurs in granular cells of other invertebrates such as the shrimp (Destoumieux et al., 1997) , crab (Shigenaga et al., 1990; Relf et al., 1999) and the mussel (Mitta et al., 1999) as part of their innate immunity.
Our preliminary experiments had indicated that a whole body extract of uninfected larvae of the housefly, Musca domestica, displayed growth inhibiting properties against bacterial cultures. Therefore, our goal was to isolate and identify the constitutive antimicrobial compound(s) present.
Materials and methods

Insect rearing
Pupae of M. domestica (Diptera, Muscidae) were obtained from a local petshop. The flies that emerged were fed on milk and dry diet (milk powder/sugar/yeast; 2/2/1). Eggs could be collected from paper strips on which they were deposited by the mature flies. Larvae were reared on an artificial diet (milk powder/yeast/agar; 100/100/20 g per litre distilled water). When the larvae are ready to start pupation, they will leave the moist diet and enter the sawdust that was spread on top, from which they can then be collected. These larvae are referred to as last instar larvae.
Extraction and sample preparation
The last instar larvae were rinsed with distilled water, dried on a paper towel and homogenised in a precooled extraction solvent consisting of methanol/water/acetic acid (90/9/1) complemented with 10 µg/ml of the protease inhibitor aprotinin (Sigma). After centrifuging the homogenate at 13,000 × g for 30 min at 4°C, the supernatant was collected. Methanol in the supernatant was removed by evaporation and the remaining residue was dissolved in 0.1% aqueous trifluoroacetic acid (TFA). Lipids were extracted by successively adding ethyl acetate and hexane, and each time removing the upper lipophilic layer that formed after vigorously shaking. Traces of these solvents were removed by short evaporation. The resulting sample was filtered through a 0.45 µm pore hydrophilic filter (Millipore) and loaded onto Megabound elute C 18 cartridges (Varian Inc.). The cartridges were previously activated by flushing them with 50 ml of acetonitrile (CH 3 CN), followed by 50 ml deionised water. After loading the sample, the cartridges were washed again with 50 ml deionised water. Next, the retained sample components were eluted sequentially with 50 ml each of 30%, 60% and 90% CH 3 CN in 0.1% aqueous TFA.
High performance liquid chromatography (HPLC)
HPLC separations were performed on a Beckman HPLC system with diode array detector. Chromatograms were constructed at 214 nm absorbance. The columns and run conditions applied for purification were successively: (1) preparative 25 × 100 mm Deltapak C 18 (Waters associates); solvent A was 0.1% aqueous TFA; solvent B was 0.1% TFA in CH 3 CN; run conditions: 0% B for 6 min then linear gradient to 100% B in 90 min; flow was 40 ml/min (2) semi preparative 7.8 × 300 mm Xterra C 18 (Waters associates); solvent A was 0.1% aqueous TFA; solvent B was 0.1% TFA in CH 3 CN; run conditions: 0% B for 10 min then linear gradient to 90% B in 60 min; flow was 1 ml/min (3) analytical 4.6 × 250 mm Suplex pkb-100 (Supelco); solvent A was 0.1% aqueous TFA; solvent B was 0.1% TFA in CH 3 CN; run conditions: 0% B for 8 min then linear gradient to 90% B in 70 min; flow was 1 ml/min.
Antimicrobial bioassay
Growth inhibiting activity was determined in liquid growth medium using the Gram-positive bacteria Bacillus thuringiensis LMG 7138, the Gram-negative bacteria Escherichia coli LMG 8063 and the yeast Saccharomyces cerevisiae ATCC 7754 as indicator organisms. B. thuringiensis and E. coli were grown in tryptic soy broth (Sigma) at 27 and 36°C, respectively. S. cerevisiae was grown in Sabouraud maltose broth (Merck) at 27°C. Overnight cultures of the bacteria and a 24 h culture of the yeast were diluted in fresh growth medium to a concentration of approximately 5 × 10 5 cells / ml. From these dilutions, 10 µl inocula were taken and placed in the wells of a 96-well microtiter plate. Aliquots of the HPLC samples to be tested were concentrated under vacuum to remove all traces of CH 3 CN and TFA. The residues were dissolved in 40 µl suitable growth medium and added to the inocula in the wells. Controls consisted of 10 µl inoculum in 40 µl growth medium. Bacterial growth was evaluated after an incubation of 6 h, growth rate of the yeast was evaluated after an overnight incubation. The occurrence of growth inhibition was assessed by visual observation using an inverted light microscope (Nikon) and confirmed by absorbance measurement at 595 nm.
Mass spectrometry analysis
Electrospray ionisation quadrupole time-of-flight (ESI-Q-TOF) mass spectrometry was performed on a Q-TOF system (Micromass). The purified active molecule was identified by accurate mass analysis and fragmentation of the ion using collision induced dissociation (CID). Two microlitre of acetonitrile/water/formic acid (80/19.9/0.1) containing the purified active compound was loaded in a gold coated glass capillary needle (L/Q needle, Proxeon) and sprayed from the needle with a flow rate of 30 nl/min. Spectra were recorded in the positive ion mode. Accurate mass measurements were performed by using the single protonated mass of riboflavine as a lock mass for internal calibration, which gives a mass accuracy of less than 10 ppm (parts per million). Using the elemental mass software (Masslynx 3.5, Micromass), any possible combination of prechosen atomic masses was calculated to match the measured mass within the predefined accuracy limits.
Nuclear magnetic resonance (NMR) analysis
A one-dimensional 1 H NMR spectrum was recorded in CH 3 OD on a Varian Unity 600 apparatus (Varian Inc.) at 600 MHz, using the residual O-H signal as internal calibration. The peak assignment was made by comparison with literature data (Mena et al., 1985) .
Results
Antimicrobial activity in a larval extract of M. domestica
An acidic extract of approximately 9300 last instar larvae (80 g) was prepared and loaded onto a solid phase C 18 cartridge. Fractions, as eluted from the cartridge, were tested for antimicrobial activity. The results are presented in Table 1 . Antimicrobial activity against B. thuringiensis and S. cerevisiae was found in the fractions eluting with 60% and 90% CH 3 CN in 0.1% aqueous TFA. No antimicrobial activity was observed against E. coli up to a concentration of 30 larval equivalents.
The antimicrobial activity in the fraction eluting with 60% CH 3 CN in 0.1% aqueous TFA was lost upon further purification. The fraction eluting with 90% CH 3 CN in 0.1% aqueous TFA was further purified on a preparative reversed phase HPLC column (chromatogram not shown). Two adjacent fractions inhibited growth of both B. thuringiensis and S. cerevisiae. These fractions were pooled and further purified on two different reversed phase HPLC columns (Fig. 1) . Antimicrobial activity was detected each time in a single fraction. After the third purification step, a pure fraction was obtained. In rough estimate, the quantity of sample necessary to inhibit growth of B. thuringiensis in our 50 µl liquid bioassay was calculated to be derived from an extract of 30 larval equivalents, all loss of material due to the sequential purification steps included. 
Identification of 1-lysophosphatidylethanolamine
A mass spectrometrical analysis indicated a mass of 452.2 Da (M + H + ) (Fig. 2a) . The Na + adduct (m/z 474.2), K + adduct (m/z 490.2), K + H + adduct (m/z 245.6) and dimeric ion (m/z 903.5) were also observed in the mass spectrum, together with some fragment ions. Collision-induced dissociation of the ion at m/z 452.2 resulted in several distinctive fragments, among which a dominant ion at m/z 311.2 (Fig. 2b) .
NMR analysis of the purified active molecule revealed the presence of a mono-unsaturated C 16 acyl chain and a glycerol moiety, with the acyl chain positioned on the second carbon of the glycerol backbone (Table 2) . Although the position of the double carbon bond is not undisputedly determined, it is most likely present in the delta 9 position.
These data, together with the mass spectrometry data, identified the antimicrobial substance as 2-palmitoyl-1-hydroxy-sn-glycero-3-phosphoethanolamine or 1-lysophosphatidylethanolamine (C 16:1 ) (1-LPE). The corresponding molecular formula, C 21 H 42 NO 7 P, was indicated by elemental mass analysis within an accuracy of 5 ppm.
The dominant ion at m/z 311.2 in the fragmentation spectrum is obtained after 1-LPE loses the phosphatidylethanolamine group and corresponds thus to the acylated glycerol (Fig. 3) . Further loss of the CH 2 OH group from this fragment results in the ion at m/z 280.3. Further loss of the glycerol from this fragment results in the ion at m/z 237.2 thus corresponding to the C 16 acyl chain less OH. Also, a series of fragments, starting from the ion at m/z 163.1 and ending with the ion at m/z 93.1, can be observed in the fragmentation spectrum and illustrates the repeated loss of a CH 2 -group (14 Da) from the acyl chain.
Discussion
We have isolated and identified 1-LPE in last instar larvae of M. domestica, based on its growth inhibiting properties against the Gram-positive bacteria B. thuringiensis and the yeast S. cerevisiae. The fraction containing 1-LPE did not inhibit growth of the Gram-negative bacteria E. coli in the bioassay as described.
LPE are present in small quantities as integral elements of membranes of animals, plants and bacteria. They are formed by hydrolysis of the structural membrane component phosphatidylethanolamine (PE) by phospholipase A 1 (formation of 1-LPE) and phospholipase A 2 (formation of 2-LPE). During the extraction of uninfected larvae, the concentration of free LPE may have increased due to the degradation of cellular membranes and the release of phospholipases. However, it should be considered that to a certain extent we are mimicking the cell degradation that occurs in the course of an infection, and which will consequently also result in an increase of LPE in the hemolymph, initiating a cascade of hemolymph component interactions (further substantiated in final paragraph).
The antimicrobial activity of rimenophenazine antibiotic agents was shown to be mediated by the release of lysophospholipids. 2-LPE and lysophosphatidylcholine (LPC) have inhibited growth of Gram-positive bacteria with minimal growth inhibitory concentrations (MIC 100 ) of 5-20 µg/ml, whereas Gram-negative bacteria are resistant at these concentrations (Van Rensburg et al., 1992) . This selectivity is apparently due to the selective inhibition of bacterial K + -transport systems, as demonstrated for LPC (De Bruyn et al., 1996; Steel et al., 1999) . Gram-positive bacteria possess only a single operative K + -uptake system in normal growth conditions, whereas Gram-negative bacteria, as well as mammalian cells for that matter, use diverse transport systems for K + -uptake and are thus not lethally affected by a selective system inhibition (Kakinuma, 1993) . As structural differences between mammalian and bacterial K + -channels have been described (Steel et al., 1999; Wrisch and Grissmer, 2000) , these observations may become a basis for structure-guided development of new selective antimicrobial agents.
Importantly, it should be noted that researchers generally refer to LPE or simply lysophospholipids in general, without specifying structural features. However, significant differences in activity of structurally different lysophospholipids are observed. Researchers have reported that the observed haemolytic effect of LPC as well as the phospholipase D (PLD) inhibiting effect of LPE dramatically increase with the length and unsaturation of the acyl chain and that only the intact LPE molecule is capable of inhibiting PLD (Ginsburg et al., 1989; Ryu et al., 1997) . LPC, but not LPE, are haemolytic and can enhance superoxide responses in stimulated neutrophils (Ginsburg et al., 1989) . Also, LPC-induced cellular injury can be inhibited by antioxidants, but not the LPEinduced injury (Colles and Chisolm, 2000) . These observations suggest that the specific structural configuration of the lysophospholipids is determinative for their effects in vivo.
Our data clearly indicated that the purified substance is conform to a 1-LPE (C 16:1 ) compound, with the acyl chain on the sn-2 position of the glycerol moiety. The reactive hydroxyl-group at the sn-1 position is thus much more accessible in 1-LPE in comparison to its sn-2 position in the structural analogue 2-LPE, where it is partially shielded by the acyl chain at the sn-1 position. Therefore, it would be plausible that 1-LPE displays a higher reactivity in comparison. However, to exactly determine the hemolymph titre and active concentration, we needed to obtain a quantified reference of 1-LPE. Unfortunately, the compound as we purified it was not synthetically available and would not be synthesized on request, as Avanti Polar Lipids Inc. informed us, because the product is not very stable during chemical synthesis. The analogous 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine (2-LPE; C 16:0 ) was then ordered and tested in our liquid growth inhibition bioassay. No activity against B. thuringiensis or S. cerevisiae was detected at concentrations up to 125 µg/ml, in contrast to the report by Van Rensburg et al. (1992) . However, growth inhibition in the bioassay used by Van Rensburg was assessed through the stop in bacterial uptake of radiolabeled amino acids and is bound to be more sensitive than our bioassay. Thus, this observation seems to confirm our suggestion that the growth inhibiting properties of our isolated 1-LPE are stronger then those of the analogous 2-LPE tested, as they were detected by our less sensitive bioassay.
In addition to antibacterial activity, we observed a growth inhibiting action of 1-LPE against the yeast S. cerevisiae. The antifungal action of 1-LPE remains undetermined at the moment. Possibly, the general reversible membrane-destabilising effect of the amphipathic lysophospholipids may provide a basis for this activity (Colles and Chisolm, 2000) . However, a structure-specific action of 1-LPE must again not be excluded.
Finally, our data seem to be complemented by parallel ongoing research in our laboratory on the immune response of Drosophila melanogaster. Vierstraete et al. (2003) demonstrated the upregulated presence of a PEbinding protein in larval hemolymph of D. melanogaster, 25 min after induction of the immune response. In addition, a recent study by Yajima et al. (2003) reported that phospholipase A 2 (PLA 2 ) activity became upregulated after E. coli infection of Sarchophaga peregrina. The PLA 2 -generated fatty acids, predominantly the eicosanoid precursors, specifically participated in the activation of the intracellular imd-pathway, leading to the synthesis of antimicrobial peptides. One might speculate that the hemolymph concentration of LPE becomes increased by the infection-induced upregulation of PLAactivity and/or by its release from damaged cell membranes and that these LPE subsequently bind to invading microorganisms, thus causing not only the demonstrated microbial growth inhibition but also a further induction of the immune response by a signal transduction pathway that involves infection-induced (L)PE binding proteins. Future analyses will further reveal the role of LPE in the immune response.
In conclusion, we propose that the specific structural configuration of the isolated 1-LPE compound may enhance its antimicrobial reactivity in comparison to its 2-LPE analogue and provide a promising lead compound for selective cellular regulation. 
